SAFETY
Clinical trials for SAFETY explained in plain language.
Never miss a new study
Get alerted when new SAFETY trials appear
Sign up with your email to follow new studies for SAFETY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Breakthrough stem cell trial aims to restore movement after spinal injury
Disease control Not yet recruitingThis study is testing whether a lab-made stem cell product called XS228 can help repair nerve damage and improve movement in people with recent spinal cord injuries. About 60 adults with injuries that occurred 2-12 weeks ago will receive either the stem cell injection or a placeb…
Matched conditions: SAFETY
Phase: PHASE2 • Sponsor: XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Can training bar staff stop violence before it happens?
Prevention Not yet recruitingThis study is testing a program called Safe Night Out that trains bar staff to recognize warning signs of sexual violence and intimate partner violence and safely intervene. Researchers will compare 50 bars in Sacramento, half with the training and half without, by surveying 650 …
Matched conditions: SAFETY
Sponsor: University of California, San Diego • Aim: Prevention
Last updated Mar 19, 2026 14:56 UTC
-
New nasal spray aims to calm nerves before surgery
Symptom relief Not yet recruitingThis study is testing the safety and effectiveness of a sedative nasal spray given to patients before they receive anesthesia for surgery. Researchers want to see if the spray helps patients relax without causing serious breathing or heart problems. They will compare the spray to…
Matched conditions: SAFETY
Phase: PHASE4 • Sponsor: Sichuan Provincial People's Hospital • Aim: Symptom relief
Last updated Apr 01, 2026 14:42 UTC
-
New Pill's first human test begins: is it safe?
Knowledge-focused Not yet recruitingThis is the first study in humans of a new oral medication called YR011. Researchers will test its safety and how the body processes it in 64 healthy volunteers. The study will give people single and multiple doses to check for side effects before testing in patients with specifi…
Matched conditions: SAFETY
Phase: PHASE1 • Sponsor: Hangzhou Yirui Pharmaceutical Technology Co., Ltd • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC